Aktie A3ENW4 ACCELERATE DIAGNOSTICS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Accelerate Diagnostics, Inc.

Aktien

A3ENW4

US00430H2013

AXDX

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:30:00 26.04.2024 		% 5 Tage % 1. Jan.
0,9301 USD -1,61 % Intraday Chart für Accelerate Diagnostics, Inc. +8,28 % -76,27 %
29.03. Accelerate Diagnostics, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
28.03. Transcript : Accelerate Diagnostics, Inc., Q4 2023 Earnings Call, Mar 28, 2024

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Certain Warrants of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
Certain Restricted Stock Units of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
Certain Common Stock of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
Certain Stock Options of Accelerate Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 19-APR-2024.
Accelerate Diagnostics : Announces 510(k) Submission of the Accelerate Arc™ System to the FDA
Accelerate Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.
Accelerate Diagnostics, Inc. announced that it expects to receive $4.749996 million in funding from Jack W. Schuler Living Trust
Top Midday Decliners
Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement
Sector Update: Health Care Stocks Weaker Late Afternoon
Sector Update: Health Care
Top Midday Decliners
Accelerate Diagnostics Announces Launch of Proposed Public Offering
Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results
Accelerate Diagnostics, Inc. Announces Preliminary Unaudited Revenue Results for the Year Ended December 31, 2023
Accelerate Diagnostics Announces Collaboration for the Use of the Arc System in Combination with Bruker's MALDI Biotyper
Accelerate Diagnostics Announces Collaboration for the Use of the Arc System in Combination With Bruker´s MALDI Biotyper
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3ENW4 Aktie
  4. Nachrichten Accelerate Diagnostics, Inc.
  5. Andere Sprachen